文献速递腹部CT

光谱探测器CT肝脏碘定量的精度与可靠性:体模与患者数据证据

Precision and reliability of liver iodine quantification from spectral detector CT: evidence from phantom and patient data.
PubMed 文献 · Eur Radiol · 2018-10-15

该回顾性研究纳入77例按临床指征接受2次(52例)或3次(25例)腹部检查的患者,并用拟人肝体模验证光谱探测器CT碘图的可重复性。体模各次检查差异<2%;患者重复检查间变异较大,80%患者差异在±20%以内,良性肝病灶差异更高。作者认为患者重复检查间较大差异可能源于生物学分布不同,强调临床需谨慎解读并进一步优化方案。

要点

  • 体模中光谱探测器CT碘定量可重复性好,各次检查差异<2%。
  • 患者重复检查间碘图变异较大,80%患者差异在±20%以内。
  • 良性肝病灶(囊肿与血管瘤)碘图重复检查差异高于肝实质。

核心结论

  • 光谱探测器CT碘图在体模中可可靠定量碘含量;患者重复检查间差异较大,可能源于生物学分布不同,强调临床需谨慎解读并进一步优化扫描方案。

研究设计与样本

  • IRB批准的回顾性研究,纳入77例按临床指征接受2次(n=52)或3次(n=25)腹部检查的患者,并使用拟人肝体模;患者采用标准化方案(SSDE 15.8 mGy),静脉注射对比剂后以团注跟踪技术采集门静脉期图像;体模在三个时间点各扫描三次,其中一次采集重复重建三次。

关键影像表现/征象

  • 所有体模检查间差异<2%。
  • 患者两次检查间变异:门静脉CI的CV为2.5%、IM的CV为3.2%;肝实质CI的CV为-0.5%、IM的CV为-3.0%。
  • 80%患者两次检查间差异在±20%以内。
  • 良性肝病灶(囊肿n=29、血管瘤n=29)重复检查差异更高,CI为68%、IM为38%。

诊断标准与关键数值

  • 以变异系数(CV[%])比较重复采集间差异。
  • 体模各次检查差异<2%。
  • 患者两次检查间门静脉CI的CV为2.5%、IM的CV为3.2%;肝实质CI的CV为-0.5%、IM的CV为-3.0%。
  • 80%患者两次检查间差异在±20%以内。
  • 良性肝病灶重复检查差异CI为68%、IM为38%。

临床应用与阅片要点

  • 作者指出临床解读碘图时应谨慎,并应考虑个体内碘分布随时间的变化。
  • 作者指出需进一步优化扫描方案。

局限性

  • 患者重复检查间差异较大,作者认为可能源于生物学分布不同。
  • 作者指出需进一步优化扫描方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To comprehensively assess precision, reproducibility, and repeatability of iodine maps from spectral detector CT (SDCT) in a phantom and in patients with repetitive examination of the abdomen.

METHODS: Seventy-seven patients who underwent examination two (n = 52) or three (n = 25) times according to clinical indications were included in this IRB-approved, retrospective study. The anthropomorphic liver phantom and all patients were scanned with a standardized protocol (SSDE in patients 15.8 mGy). In patients, i.v. contrast was administered and portal venous images were acquired using bolus-tracking technique. The phantom was scanned three times at three time points; in one acquisition, image reconstruction was repeated three times. Region of interest (ROI) were placed automatically (phantom) or manually (patients) in the liver parenchyma (mimic) and the portal vein; attenuation in conventional images (CI [HU]) and iodine map concentrations (IM [mg/ml]) were recorded. The coefficient of variation (CV [%]) was used to compare between repetitive acquisitions. If present, additional ROI were placed in cysts (n = 29) and hemangioma (n = 29).

RESULTS: Differences throughout all phantom examinations were < 2%. In patients, differences between two examinations were higher (CV for CI/IM: portal vein, 2.5%/3.2%; liver parenchyma, -0.5%/-3.0% for CI/IM). In 80% of patients, these differences were within a ± 20% limit. Differences in benign liver lesions were even higher (68% and 38%, for CI and IM, respectively).

CONCLUSIONS: Iodine maps from SDCT allow for reliable quantification of iodine content in phantoms; while in patients, rather large differences between repetitive examinations are likely due to differences in biological distribution. This underlines the need for careful clinical interpretation and further protocol optimization.

KEY POINTS: • Spectral detector computed tomography allows for reliable quantification of iodine in phantoms. • In patients, the offset between repetitive examinations varies by 20%, likely due to differences in biological distribution. • Clinically, iodine maps should be interpreted with caution and should take the intra-individual variability of iodine distribution over time into account.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Große Hokamp N, Abdullayev N, Persigehl T, et al. Precision and reliability of liver iodine quantification from spectral detector CT: evidence from phantom and patient data. Eur Radiol. 2018. PMID: 30324387. doi:10.1007/s00330-018-5744-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。